Regulation 24 Amendment of regulation 31 (certification of manufacturer's licence)I1
United Kingdom
(1)
Regulation 31 is amended as follows.
(2)
In paragraph (1)(c), for “an EEA State” substitute “ the United Kingdom ”.
F1(3)
In paragraphs (3)(b), (5)(a) and (5)(b) for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation, Article 126a authorisation”.
Annotations
Textual amendments
- F1
Reg. 24(3) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 16
Commencement
- I1
Reg. 24 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1